01 1Albemarle Corporation
01 1LITHIUM CARBONATE USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-04-02
Pay. Date : 2013-03-26
DMF Number : 4242
Submission : 1981-08-12
Status : Active
Type : II
20
Albemarle Corp, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is LITHIUM CARBONATE USP, with a corresponding US DMF Number 4242.
Remarkably, this DMF maintains an Active status since its submission on August 12, 1981, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 02, 2013, and payment made on March 26, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
